ID   SANi003-A
AC   CVCL_QY86
SY   MEE630.cl5
DR   hPSCreg; SANi003-A
DR   Wikidata; Q54952093
RX   PubMed=29040913;
CC   From: Sanquin; Amsterdam; Netherlands.
CC   Caution: Indicated in PubMed=29040913 to originate from a female donor, but the karyotype is X,Y and the amelogenin STR locus is also X,Y.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
ST   Source(s): PubMed=29040913
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 12,13
ST   D21S11: 28,29
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 10,13
ST   FGA: 19,20
ST   Penta D: 9,13
ST   Penta E: 5,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QY87 ! SANi003-B
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
RX   PubMed=29040913; DOI=10.1016/j.scr.2017.10.001;
RA   Varga E., Hansen M., Wust T., von Lindern M., van den Akker E.;
RT   "Generation of human erythroblast-derived iPSC line using episomal
RT   reprogramming system.";
RL   Stem Cell Res. 25:30-33(2017).
//